Johnson & Johnson Raises a Flag in Early-Stage Lung Cancer with First-Ever Contest in the Field

Primary tabs

Johnson & Johnson Raises a Flag in Early-Stage Lung Cancer with First-Ever Contest in the Field

J&J is targeting lung cancer in its latest QuickFire Innovation Challenge, putting out the word for creative and inventive new ideas. (Johnson & Johnson)

J&J is targeting lung cancer in its latest QuickFire Innovation Challenge, putting out the word for creative and inventive new ideas. (Johnson & Johnson)

tweet me:
Johnson & Johnson Raises a Flag in Early-Stage Lung Cancer with First-Ever Contest in the Field @JNJNews #healthforhumanity http://bit.ly/2A2r1Mr
Friday, October 12, 2018 - 11:10am

CAMPAIGN: Eradicating and Preventing Disease

CONTENT: Article

No question about it, the lung cancer field is hot—and chock-full of new drugs and combos. But there's a dearth of treatments specifically for early-stage disease, and Johnson & Johnson is looking to crowdsourcing to bring in new ideas.

It's doing that through its latest QuickFire contest at JLABS, the company's internal life sciences incubator. The winner of the Lung Cancer Innovation QuickFire Challenge will earn a yearlong residency at JLABS @ Shanghai, the newest of its 11 labs around the world.

Click here to continue reading

Keywords: Health & Healthcare | Lung Cancer Innovation QuickFire Challenge | johnson & johnson | lung cancer | preventing disease

CAMPAIGN: Eradicating and Preventing Disease

CONTENT: Article